Familial hypercholesterolaemia is a common inherited disorder characterized by abnormally
elevated serum levels of low-density lipoprotein (LDL) cholesterol from birth, which in time …

Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management,
multidisciplinary teamwork, involvement of primary care practitioners, patient networks …

Importance Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated
genetic disorder that leads to premature morbidity and mortality due to atherosclerotic …

Background and aims Management of familial hypercholesterolaemia (FH) may vary across
different settings due to factors related to population characteristics, practice, resources …

Cholesterol is an essential component of cell barrier formation and signaling transduction
involved in many essential physiologic processes. For this reason, cholesterol metabolism …

Familial hypercholesterolaemia (FH) is a dominant and highly penetrant monogenic
disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL) …

Summary Background The European Atherosclerosis Society Familial
Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for …

Background and aims Patients with familial hypercholesterolaemia (FH) have an elevated
risk of coronary heart disease (CHD). Here we compare changes in CHD mortality in …

Familial hypercholesterolemia (FH) is an autosomal codominant lipoprotein disorder
characterized by elevated low-density lipoprotein cholesterol (LDL-C) and high risk of …

The resident microbiome plays a key role in exposure of the upper gastrointestinal (GI) tract
mucosa to acetaldehyde (ACH), a carcinogenic metabolite of ethanol. Poor oral health is a …